Vertex, Kymera join forces for developing protein degradation drugs
Category: #health  By Nikita Chaurasia  Date: 2019-05-17
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Vertex, Kymera join forces for developing protein degradation drugs

Vertex would be paying $70 million in advance to work with Kymera including an equity investment in the company

Kymera Therapeutics and Vertex Pharmaceuticals Incorporated (VRTX) have reportedly announced that they are entering into a four-year research and development partnership to discover and develop small molecule protein degraders against various targets.

Sources close to the matter mentioned that the partnership will leverage Kymera’s expertise in its proprietary Pegasus™ drug discovery platform and in targeted protein degradation and Vertex’s clinical, scientific, and regulatory capabilities. It will boost the development of first in class medicines for people suffering from serious diseases.

According to Senior Vice President and Site Head of Boston Research at Vertex, Mark Bunnage, this partnership with Kymera Therapeutics will improve the company’s drug discovery capabilities and reinforce the approach of investing in scientific innovation to develop transformative drugs for serious diseases.

As per the terms of the four-year deal, Vertex would be paying $70 million in advance to work with Kymera including an equity investment in the company. Under the collaboration, Kymera will conduct research activities in several targets. Once a clinical development candidate is selected, Vertex has the option to completely license molecules against the selected target.

On the other hand, Kymera is also eligible to receive over $1 billion in potential payments based upon the successfully achieving research, development, commercial, and regulatory milestones for up to six programs optioned as part of the partnership, sourced mentioned.

President and CEO of Kymera Therapeutics, Dr. Laurent Audoly, Ph.D., said that this strategic partnership will widen the application of targeted protein degradation for addressing serious diseases having limited or no treatment options.

For the uninitiated, Kymera Therapeutics is a biotechnology company pioneering a new and transformative approach towards treating serious diseases which were previously untreatable. The company advances in the field of targeted protein degradation and disease-causing proteins to tackle substantial unmet medical need.

 

Source Credit: https://finance.yahoo.com/news/vertex-kymera-therapeutics-establish-strategic-123000590.html

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Nokia partners with LG Uplus to expand 5G coverage in South Korea

Nokia partners with LG Uplus to expand 5G coverage in South Korea

By Nikita Chaurasia

Finnish telecommunications giant Nokia Corporation has reportedly signed a joint venture agreement with LG Uplus, a prominent cellular carrier, to expand 5G coverage in South Korea. The duo intends to achieve this by deploying Nokia’s end-to-e...

Mercedes-Benz unveils the S-Class of EVs, comes with a 56-inch display

Mercedes-Benz unveils the S-Class of EVs, comes with a 56-inch display

By Nikita Chaurasia

Mercedes-Benz, a German multinational automaker of luxury and commercial vehicles, has unveiled its flagship electric sedan, the EQS. The new vehicle is likely to allow Mercedes to take on Tesla Inc., as the market for electric vehicles (EVs) continu...

Ford takes on GM, Tesla by debuting its first hands-free driving system

Ford takes on GM, Tesla by debuting its first hands-free driving system

By Nikita Chaurasia

Ford Motor Company, the American multinational automaker, is reportedly planning on introducing a hands-free driving feature on its 2021 Mustang Models as well as 2021 F-150 pickup truck through a software update, by the end of the year. The automob...